Evidence map›Paper›PMID 41663760›Full record

ArticleEMBO reports2026

Oligomerization-dependent and synergistic regulation of Cdc42 GTPase cycling by a GEF and a GAP.

Sophie Tschirpke, Werner K-G Daalman, Frank van Opstal, Liedewij Laan

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Sortase A-Mediated Farnesylation of Cdc42ACS synthetic biology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sophie TschirpkeBionanoscience Department, Delft University of Technology, Delft, The Netherlands.ORCID 0009-0005-6550-9291
Werner K-G DaalmanBionanoscience Department, Delft University of Technology, Delft, The Netherlands.
Frank van OpstalBionanoscience Department, Delft University of Technology, Delft, The Netherlands.
Liedewij LaanBionanoscience Department, Delft University of Technology, Delft, The Netherlands. L.Laan@tudelft.nl.ORCID 0000-0002-7138-9004

Funding

EC | European Research Council (ERC) 758132Netherlands Organization for Scientific Research (NWO) 16.Vidi.171.060
6 · The paper itself

Abstract

Cell polarity is a crucial biological process essential for cell division, directed growth, and motility. In Saccharomyces cerevisiae, polarity establishment centers around the small Rho-type GTPase Cdc42, which cycles between GTP-bound and GDP-bound states, regulated by GEFs like Cdc24 and GAPs such as Rga2. To dissect the dynamic regulation of Cdc42, we employed in vitro GTPase assays, revealing inverse concentration-dependent profiles for Cdc24 and Rga2: with increasing concentration, Cdc24's GEF activity is nonlinear and oligomerization-dependent, which is possibly linked to the relief of its self-inhibition. In contrast, Rga2's GAP activity saturates, likely due to self-inhibition upon oligomerization. Together, Cdc24 and Rga2 exhibit a strong synergy driven by weak Cdc24-Rga2 binding. We propose that the synergy stems from Cdc24 alleviating the self-inhibition of oligomeric Rga2. We believe this synergy contributes to efficient regulation of Cdc42's GTPase cycle over a wide range of cycling rates, enabling cells to resourcefully establish polarity. As Cdc42 is highly conserved among eukaryotes, we propose the GEF-GAP synergy to be a general regulatory property in other eukaryotes.

Indexed as

cdc42 GTP-Binding Protein, Saccharomyces cerevisiaeCell Cycle ProteinsGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsProtein MultimerizationSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCell PolarityProtein BindingCDC24 protein, S cerevisiaecdc42 GTP-Binding Protein, Saccharomyces cerevisiaeCell Cycle ProteinsGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsSaccharomyces cerevisiae ProteinsCdc42 RegulationEnzyme KineticsGEF-GAP SynergyGTPase ActivityOligomerization

Identifiers

PMID41663760
PMCPMC13022455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.